Stay updated with breaking news from Exact Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exact Sciences Co. (NASDAQ:EXAS – Free Report) – Investment analysts at Leerink Partnrs boosted their Q1 2024 EPS estimates for Exact Sciences in a research note issued to investors on Wednesday, February 21st. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will earn ($0.36) per share for the quarter, up from […]
The test, using blood or saliva, can evaluate genetic risk for colorectal, breast, prostate, skin, ovarian, endometrial, pancreatic, gastric, kidney and endocrine cancers.
The test, using blood or saliva, can evaluate genetic risk for colorectal, breast, prostate, skin, ovarian, endometrial, pancreatic, gastric, kidney and endocrine cancers.
The test, using blood or saliva, can evaluate genetic risk for colorectal, breast, prostate, skin, ovarian, endometrial, pancreatic, gastric, kidney and endocrine cancers.
